Eintrag weiter verarbeiten
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open...
Gespeichert in:
| Zeitschriftentitel: | Annals of Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| In: | Annals of Oncology, 28, 2017, 10, S. 2443-2450 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Elsevier BV
|
| Schlagwörter: |
| author_facet |
Shi, Y.K. Wang, L. Han, B.H. Li, W. Yu, P. Liu, Y.P. Ding, C.M. Song, X. Ma, Z.Y. Ren, X.L. Feng, J.F. Zhang, H.L. Chen, G.Y. Han, X.H. Wu, N. Yao, C. Song, Y. Zhang, S.C. Song, W. Liu, X.Q. Zhao, S.J. Lin, Y.C. Ye, X.Q. Li, K. Shu, Y.Q. Ding, L.M. Tan, F.L. Sun, Y. Shi, Y.K. Wang, L. Han, B.H. Li, W. Yu, P. Liu, Y.P. Ding, C.M. Song, X. Ma, Z.Y. Ren, X.L. Feng, J.F. Zhang, H.L. Chen, G.Y. Han, X.H. Wu, N. Yao, C. Song, Y. Zhang, S.C. Song, W. Liu, X.Q. Zhao, S.J. Lin, Y.C. Ye, X.Q. Li, K. Shu, Y.Q. Ding, L.M. Tan, F.L. Sun, Y. |
|---|---|
| author |
Shi, Y.K. Wang, L. Han, B.H. Li, W. Yu, P. Liu, Y.P. Ding, C.M. Song, X. Ma, Z.Y. Ren, X.L. Feng, J.F. Zhang, H.L. Chen, G.Y. Han, X.H. Wu, N. Yao, C. Song, Y. Zhang, S.C. Song, W. Liu, X.Q. Zhao, S.J. Lin, Y.C. Ye, X.Q. Li, K. Shu, Y.Q. Ding, L.M. Tan, F.L. Sun, Y. |
| spellingShingle |
Shi, Y.K. Wang, L. Han, B.H. Li, W. Yu, P. Liu, Y.P. Ding, C.M. Song, X. Ma, Z.Y. Ren, X.L. Feng, J.F. Zhang, H.L. Chen, G.Y. Han, X.H. Wu, N. Yao, C. Song, Y. Zhang, S.C. Song, W. Liu, X.Q. Zhao, S.J. Lin, Y.C. Ye, X.Q. Li, K. Shu, Y.Q. Ding, L.M. Tan, F.L. Sun, Y. Annals of Oncology First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study Oncology Hematology |
| author_sort |
shi, y.k. |
| spelling |
Shi, Y.K. Wang, L. Han, B.H. Li, W. Yu, P. Liu, Y.P. Ding, C.M. Song, X. Ma, Z.Y. Ren, X.L. Feng, J.F. Zhang, H.L. Chen, G.Y. Han, X.H. Wu, N. Yao, C. Song, Y. Zhang, S.C. Song, W. Liu, X.Q. Zhao, S.J. Lin, Y.C. Ye, X.Q. Li, K. Shu, Y.Q. Ding, L.M. Tan, F.L. Sun, Y. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdx359 First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study Annals of Oncology |
| doi_str_mv |
10.1093/annonc/mdx359 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR4MzU5 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR4MzU5 |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Elsevier BV, 2017 |
| imprint_str_mv |
Elsevier BV, 2017 |
| issn |
0923-7534 |
| issn_str_mv |
0923-7534 |
| language |
English |
| mega_collection |
Elsevier BV (CrossRef) |
| match_str |
shi2017firstlineicotinibversuscisplatinpemetrexedpluspemetrexedmaintenancetherapyforpatientswithadvancedegfrmutationpositivelungadenocarcinomaconvinceaphase3openlabelrandomizedstudy |
| publishDateSort |
2017 |
| publisher |
Elsevier BV |
| recordtype |
ai |
| record_format |
ai |
| series |
Annals of Oncology |
| source_id |
49 |
| title |
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_unstemmed |
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_full |
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_fullStr |
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_full_unstemmed |
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_short |
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_sort |
first-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedegfr mutation-positive lung adenocarcinoma (convince): a phase 3, open-label, randomized study |
| topic |
Oncology Hematology |
| url |
http://dx.doi.org/10.1093/annonc/mdx359 |
| publishDate |
2017 |
| physical |
2443-2450 |
| description |
|
| container_issue |
10 |
| container_start_page |
2443 |
| container_title |
Annals of Oncology |
| container_volume |
28 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792347067288387591 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:49:21.193Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=First-line+icotinib+versus+cisplatin%2Fpemetrexed+plus+pemetrexed+maintenance+therapy+for+patients+with+advancedEGFR+mutation-positive+lung+adenocarcinoma+%28CONVINCE%29%3A+a+phase+3%2C+open-label%2C+randomized+study&rft.date=2017-10-01&genre=article&issn=0923-7534&volume=28&issue=10&spage=2443&epage=2450&pages=2443-2450&jtitle=Annals+of+Oncology&atitle=First-line+icotinib+versus+cisplatin%2Fpemetrexed+plus+pemetrexed+maintenance+therapy+for+patients+with+advancedEGFR+mutation-positive+lung+adenocarcinoma+%28CONVINCE%29%3A+a+phase+3%2C+open-label%2C+randomized+study&aulast=Sun&aufirst=Y.&rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdx359&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792347067288387591 |
| author | Shi, Y.K., Wang, L., Han, B.H., Li, W., Yu, P., Liu, Y.P., Ding, C.M., Song, X., Ma, Z.Y., Ren, X.L., Feng, J.F., Zhang, H.L., Chen, G.Y., Han, X.H., Wu, N., Yao, C., Song, Y., Zhang, S.C., Song, W., Liu, X.Q., Zhao, S.J., Lin, Y.C., Ye, X.Q., Li, K., Shu, Y.Q., Ding, L.M., Tan, F.L., Sun, Y. |
| author_facet | Shi, Y.K., Wang, L., Han, B.H., Li, W., Yu, P., Liu, Y.P., Ding, C.M., Song, X., Ma, Z.Y., Ren, X.L., Feng, J.F., Zhang, H.L., Chen, G.Y., Han, X.H., Wu, N., Yao, C., Song, Y., Zhang, S.C., Song, W., Liu, X.Q., Zhao, S.J., Lin, Y.C., Ye, X.Q., Li, K., Shu, Y.Q., Ding, L.M., Tan, F.L., Sun, Y., Shi, Y.K., Wang, L., Han, B.H., Li, W., Yu, P., Liu, Y.P., Ding, C.M., Song, X., Ma, Z.Y., Ren, X.L., Feng, J.F., Zhang, H.L., Chen, G.Y., Han, X.H., Wu, N., Yao, C., Song, Y., Zhang, S.C., Song, W., Liu, X.Q., Zhao, S.J., Lin, Y.C., Ye, X.Q., Li, K., Shu, Y.Q., Ding, L.M., Tan, F.L., Sun, Y. |
| author_sort | shi, y.k. |
| container_issue | 10 |
| container_start_page | 2443 |
| container_title | Annals of Oncology |
| container_volume | 28 |
| description | |
| doi_str_mv | 10.1093/annonc/mdx359 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR4MzU5 |
| imprint | Elsevier BV, 2017 |
| imprint_str_mv | Elsevier BV, 2017 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 0923-7534 |
| issn_str_mv | 0923-7534 |
| language | English |
| last_indexed | 2024-03-01T17:49:21.193Z |
| match_str | shi2017firstlineicotinibversuscisplatinpemetrexedpluspemetrexedmaintenancetherapyforpatientswithadvancedegfrmutationpositivelungadenocarcinomaconvinceaphase3openlabelrandomizedstudy |
| mega_collection | Elsevier BV (CrossRef) |
| physical | 2443-2450 |
| publishDate | 2017 |
| publishDateSort | 2017 |
| publisher | Elsevier BV |
| record_format | ai |
| recordtype | ai |
| series | Annals of Oncology |
| source_id | 49 |
| spelling | Shi, Y.K. Wang, L. Han, B.H. Li, W. Yu, P. Liu, Y.P. Ding, C.M. Song, X. Ma, Z.Y. Ren, X.L. Feng, J.F. Zhang, H.L. Chen, G.Y. Han, X.H. Wu, N. Yao, C. Song, Y. Zhang, S.C. Song, W. Liu, X.Q. Zhao, S.J. Lin, Y.C. Ye, X.Q. Li, K. Shu, Y.Q. Ding, L.M. Tan, F.L. Sun, Y. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdx359 First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study Annals of Oncology |
| spellingShingle | Shi, Y.K., Wang, L., Han, B.H., Li, W., Yu, P., Liu, Y.P., Ding, C.M., Song, X., Ma, Z.Y., Ren, X.L., Feng, J.F., Zhang, H.L., Chen, G.Y., Han, X.H., Wu, N., Yao, C., Song, Y., Zhang, S.C., Song, W., Liu, X.Q., Zhao, S.J., Lin, Y.C., Ye, X.Q., Li, K., Shu, Y.Q., Ding, L.M., Tan, F.L., Sun, Y., Annals of Oncology, First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study, Oncology, Hematology |
| title | First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_full | First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_fullStr | First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_full_unstemmed | First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_short | First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| title_sort | first-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedegfr mutation-positive lung adenocarcinoma (convince): a phase 3, open-label, randomized study |
| title_unstemmed | First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study |
| topic | Oncology, Hematology |
| url | http://dx.doi.org/10.1093/annonc/mdx359 |